These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 15974483)

  • 1. Efficacy and safety of chunghyul-dan (qingwie-dan) in patients with hypercholesterolemia.
    Cho KH; Kang HS; Jung WS; Park SU; Moon SK
    Am J Chin Med; 2005; 33(2):241-8. PubMed ID: 15974483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liptruzet: a combination of ezetimibe and atorvastatin.
    Med Lett Drugs Ther; 2013 Jun; 55(1419):49-50. PubMed ID: 23797796
    [No Abstract]   [Full Text] [Related]  

  • 3. Atorvastatin calcium: an addition to HMG-CoA reductase inhibitors.
    Chong PH; Seeger JD
    Pharmacotherapy; 1997; 17(6):1157-77. PubMed ID: 9399600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of atorvastatin in the treatment of hypercholesterolemia associated with antiretroviral therapy.
    Palacios R; Santos J; González M; Ruiz J; Valdivielso P; Márquez M; González-Santos P
    J Acquir Immune Defic Syndr; 2002 Aug; 30(5):536-7. PubMed ID: 12154347
    [No Abstract]   [Full Text] [Related]  

  • 5. Achieving lipoprotein goals in patients at high risk with severe hypercholesterolemia: efficacy and safety of ezetimibe co-administered with atorvastatin.
    Stein E; Stender S; Mata P; Sager P; Ponsonnet D; Melani L; Lipka L; Suresh R; Maccubbin D; Veltri E;
    Am Heart J; 2004 Sep; 148(3):447-55. PubMed ID: 15389231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Lowering cholesterol. New concepts with atorvastatin].
    Internist (Berl); 1997 Jan; 38(1 Suppl):1-8. PubMed ID: 9102396
    [No Abstract]   [Full Text] [Related]  

  • 7. A preliminary study on the inhibitory effect of Chunghyul-dan on stroke recurrence in patients with small vessel disease.
    Cho K; Noh K; Jung W; Park S; Moon S; Park J; Ko C; Kim Y; Bae H
    Neurol Res; 2008 Jul; 30(6):655-8. PubMed ID: 18498682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of simvastatin and atorvastatin up to maximal recommended doses in a large multicenter randomized clinical trial.
    Illingworth DR; Crouse JR; Hunninghake DB; Davidson MH; Escobar ID; Stalenhoef AF; Paragh G; Ma PT; Liu M; Melino MR; O'Grady L; Mercuri M; Mitchel YB;
    Curr Med Res Opin; 2001; 17(1):43-50. PubMed ID: 11464446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-hypertensive effect of chunghyul-dan (qingxue-dan) on stroke patients with essential hypertension.
    Yun SP; Jung WS; Park SU; Moon SK; Ko CN; Cho KH; Kim YS; Bae HS
    Am J Chin Med; 2005; 33(3):357-64. PubMed ID: 16047554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Atorvastatin (Lipitor)].
    Carpentier Y; Ducobu J; Sternon J
    Rev Med Brux; 1999 Oct; 20(5):427-33. PubMed ID: 10582478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of rosuvastatin and atorvastatin in patients with hypercholesterolemia and a high risk of coronary heart disease: a randomized, controlled trial.
    Schwartz GG; Bolognese MA; Tremblay BP; Caplan R; Hutchinson H; Raza A; Cressman M
    Am Heart J; 2004 Jul; 148(1):e4. PubMed ID: 15215813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effective cholesterol and triglyceride lowering with atorvastatin].
    Internist (Berl); 1996 Aug; 37(8 Suppl Effektive):1-8. PubMed ID: 9404527
    [No Abstract]   [Full Text] [Related]  

  • 13. Atorvastatin--a new lipid-lowering drug.
    Med Lett Drugs Ther; 1997 Mar; 39(997):29-31. PubMed ID: 9121394
    [No Abstract]   [Full Text] [Related]  

  • 14. Ezetimibe/simvastatin vs atorvastatin in patients with type 2 diabetes mellitus and hypercholesterolemia: the VYTAL study.
    Goldberg RB; Guyton JR; Mazzone T; Weinstock RS; Polis A; Edwards P; Tomassini JE; Tershakovec AM
    Mayo Clin Proc; 2006 Dec; 81(12):1579-88. PubMed ID: 17165637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of atorvastatin on endothelial function in patients with familial hypercholesterolemia].
    Balakhonova TV; Pogorelova OA; Susekov AV; Kobylianskiĭ AG; Kuznetsova TV; Tvorogova MG; Masenko VP; Titov VN; Kukharchuk VV; At'kov OIu
    Kardiologiia; 2002; 42(1):15-21. PubMed ID: 12494218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of ezetimibe added on to atorvastatin (40 mg) compared with uptitration of atorvastatin (to 80 mg) in hypercholesterolemic patients at high risk of coronary heart disease.
    Leiter LA; Bays H; Conard S; Bird S; Rubino J; Hanson ME; Tomassini JE; Tershakovec AM
    Am J Cardiol; 2008 Dec; 102(11):1495-501. PubMed ID: 19026303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of ezetimibe added on to atorvastatin (20 mg) versus uptitration of atorvastatin (to 40 mg) in hypercholesterolemic patients at moderately high risk for coronary heart disease.
    Conard SE; Bays HE; Leiter LA; Bird SR; Rubino J; Lowe RS; Tomassini JE; Tershakovec AM
    Am J Cardiol; 2008 Dec; 102(11):1489-94. PubMed ID: 19026302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A double-blind trial on the effects of atorvastatin on glycemic control in Japanese diabetic patients with hypercholesterolemia.
    Tanaka A; Yamada N; Saito Y; Kawakami M; Ohashi Y; Akanuma Y
    Clin Chim Acta; 2001 Oct; 312(1-2):41-7. PubMed ID: 11580908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipitor (atorvastatin calcium) tablets.
    Claussen DW
    Gastroenterol Nurs; 1998; 21(5):219-20. PubMed ID: 9830966
    [No Abstract]   [Full Text] [Related]  

  • 20. Tolerability of atorvastatin in a population aged > or =65 years: a retrospective pooled analysis of results from fifty randomized clinical trials.
    Hey-Hadavi JH; Kuntze E; Luo D; Silverman P; Pittman D; Lepetri B
    Am J Geriatr Pharmacother; 2006 Jun; 4(2):112-22. PubMed ID: 16860258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.